Passage BIO, Inc. Reports Exit and Disposal Costs
Ticker: PASG · Form: 8-K · Filed: Apr 28, 2026 · CIK: 0001787297
| Field | Detail |
|---|---|
| Company | Passage Bio, Inc. (PASG) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: restructuring, disposal, 8-K
TL;DR
Passage BIO is cutting costs related to exits/disposals, expect changes.
AI Summary
Passage BIO, Inc. filed an 8-K on April 28, 2026, to report costs associated with exit or disposal activities. The filing does not specify the exact dollar amounts or the nature of the disposal activities.
Why It Matters
This filing indicates that Passage BIO, Inc. is undergoing restructuring or divesting certain assets, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates potential restructuring or asset sales, which introduces uncertainty about the company's future direction and financial health.
Key Players & Entities
- Passage BIO, Inc. (company) — Filer
- 0001787297 (company) — CIK Number
- 2026-04-28 (date) — Filing Date
FAQ
What specific activities are associated with the exit or disposal mentioned in the filing?
The filing does not specify the exact nature of the exit or disposal activities.
What is the total dollar amount of costs associated with these exit or disposal activities?
The filing does not provide a specific dollar amount for the costs associated with exit or disposal activities.
When did Passage BIO, Inc. file this 8-K report?
Passage BIO, Inc. filed this 8-K report on April 28, 2026.
What is the CIK number for Passage BIO, Inc.?
The CIK number for Passage BIO, Inc. is 0001787297.
What is the primary item reported in this 8-K filing?
The primary item reported is Item 2.05: Cost Associated with Exit or Disposal Activities.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2026 regarding Passage BIO, Inc. (PASG).